CSIMarket
 


Sight Sciences Inc   (SGHT)
Other Ticker:  
 
 

SGHT's Capital Expenditures Growth by Quarter and Year

Sight Sciences Inc 's Capital Expenditures results by quarter and year




SGHT Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.13 0.16 0.00
III Quarter September 0.30 0.27 0.29 0.00
II Quarter June 0.10 0.34 0.37 0.00
I Quarter March 0.13 0.23 0.00 0.00
FY   0.53 0.97 0.82 0.00



SGHT Capital Expenditures third quarter 2023 Y/Y Growth Comment
Sight Sciences Inc achieved in the third quarter 2023, above Company average Capital Expenditures increase of 12.59% year on year, to $ 0.30 millions.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 46 other companies have achieved higher Capital Expenditures growth. While Sight Sciences Inc ' s Capital Expenditures growth of 12.59% ranks overall at the positon no. 1246 in the third quarter 2023.




SGHT Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -18.75 % - -
III Quarter September 12.59 % -6.9 % - -
II Quarter June -70.59 % -8.11 % - -
I Quarter March -43.48 % - - -
FY   - 18.29 % - -

Financial Statements
Sight Sciences Inc 's third quarter 2023 Capital Expenditures $ 0.30 millions SGHT's Income Statement
Sight Sciences Inc 's third quarter 2022 Capital Expenditures $ 0.27 millions Quarterly SGHT's Income Statement
New: More SGHT's historic Capital Expenditures Growth >>


SGHT Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -51.85 % -44.83 % -
III Quarter September 204 % -20.59 % -21.62 % -
II Quarter June -23.08 % 47.83 % - -
I Quarter March 0 % 43.75 % - -
FY (Year on Year)   - 18.29 % - -




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #47
Healthcare Sector #166
Overall #1246

Capital Expenditures Y/Y Growth Statistics
High Average Low
-16.44 % -29.7 % -38.4 %
(Mar 31 2023)   (Jun 30 2023)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #47
Healthcare Sector #166
Overall #1246
Capital Expenditures Y/Y Growth Statistics
High Average Low
-16.44 % -29.7 % -38.4 %
(Mar 31 2023)   (Jun 30 2023)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sight Sciences Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
213.4 % 15.86 % -52.57 %
(Sep 30 2023)  


SGHT's III. Quarter Q/Q Capital Expenditures Comment
Sight Sciences Inc achieved in the III. Quarter 2023 above company average sequential Capital Expenditures doubling of 204%, to $ 0.30 millions, from $0.10 millions in the second quarter.
SGHT is undergoing a remarkable growth, not only reporting higher then regular growth, but also increasing speed, Ethan  Evans, Medical Equipment & Supplies industry consultant said.

Within Medical Equipment & Supplies industry 17 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Sight Sciences Inc 's Capital Expenditures growth quarter on quarter, overall rank is 263.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #56
Overall #263
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #56
Overall #263
Capital Expenditures Q/Q Growth Statistics
High Average Low
213.4 % 15.86 % -52.57 %
(Sep 30 2023)  


SGHT's III. Quarter Q/Q Capital Expenditures Comment
Sight Sciences Inc achieved in the III. Quarter 2023 above company average sequential Capital Expenditures doubling of 204%, to $ 0.30 millions, from $0.10 millions in the second quarter.
Sight Sciences Inc is going from strength to strength, not only reporting higher then normal increase, and also improving pace.

Within Medical Equipment & Supplies industry 17 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Sight Sciences Inc 's Capital Expenditures growth quarter on quarter, overall rank is 263.


Sight Sciences Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.66 $ 0.62 $ 0.87 $ 0.97 $ 1.00
Y / Y Capital Expenditures Growth (TTM) -34.27 % -38.4 % -16.44 % - -
Year on Year Capital Expenditures Growth Overall Ranking # 1508 # 1048 # 0 # 0 # 0
Seqeuential Capital Expenditures Change (TTM) 5.13 % -28.19 % -10.41 % -2.81 % -1.48 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1246 # 1517 # 1840 # 1841 # 823




Cumulative Capital Expenditures growth Comment
Sight Sciences Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Sight Sciences Inc 's annual Capital Expenditures decline would be -34.27% year on year to $1 millions.

In the Healthcare sector 211 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1048 to 1508.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-16.44 %
-29.7 %
-38.4 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 47
Healthcare Sector # 212
Overall # 1508

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
-16.44 %
-29.7 %
-38.4 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 47
Sector # 166
S&P 500 # 1246
Cumulative Capital Expenditures growth Comment
Sight Sciences Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Sight Sciences Inc 's annual Capital Expenditures drop would be -34.27% year on year to $1 millions.

In the Healthcare sector 211 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1048 to 1508.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-16.44 %
-29.7 %
-38.4 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 47
Healthcare Sector # 212
Overall # 1508

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
-16.44 %
-29.7 %
-38.4 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 47
Sector # 166
S&P 500 # 1246




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SGHT's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SGHT's Competitors
Capital Expenditures Growth for Sight Sciences Inc 's Suppliers
Capital Expenditures Growth for SGHT's Customers

You may also want to know
SGHT's Annual Growth Rates SGHT's Profitability Ratios SGHT's Asset Turnover Ratio SGHT's Dividend Growth
SGHT's Roe SGHT's Valuation Ratios SGHT's Financial Strength Ratios SGHT's Dividend Payout Ratio
SGHT's Roa SGHT's Inventory Turnover Ratio SGHT's Growth Rates SGHT's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Medpace Holdings Inc 21.23%$ 21.229 millions
Cytek Biosciences Inc 21.13%$ 21.130 millions
Brookdale Senior Living Inc 20.76%$ 20.763 millions
Prophase Labs Inc 20.58%$ 20.578 millions
Castle Biosciences Inc 20.46%$ 20.461 millions
Ufp Technologies Inc 20.27%$ 20.268 millions
Healthcare Services Group Inc 20.10%$ 20.102 millions
Abbott Laboratories19.91%$ 19.914 millions
Select Medical Holdings Corp19.68%$ 19.684 millions
Option Care Health Inc 19.43%$ 19.430 millions
Monte Rosa Therapeutics Inc 18.50%$ 18.500 millions
Exelixis Inc 16.54%$ 16.536 millions
Viemed Healthcare Inc 16.44%$ 16.439 millions
Dentsply Sirona Inc 15.63%$ 15.625 millions
Cns Pharmaceuticals Inc 15.19%$ 15.192 millions
Igm Biosciences Inc 13.72%$ 13.722 millions
Rxsight Inc 12.59%$ 12.586 millions
Privia Health Group Inc 12.50%$ 12.500 millions
Geron Corp12.28%$ 12.281 millions
National Research Corporation12.23%$ 12.227 millions
Ptc Therapeutics inc 12.22%$ 12.223 millions
Sight Sciences Inc 11.76%$ 11.765 millions
Mersana Therapeutics inc 10.80%$ 10.798 millions
Warby Parker Inc 9.87%$ 9.867 millions
Immunovant Inc 9.68%$ 9.677 millions
Surgery Partners Inc 9.25%$ 9.249 millions
Sab Biotherapeutics Inc 8.66%$ 8.665 millions
Lightwave Logic Inc 8.50%$ 8.500 millions
Ati Physical Therapy Inc 8.28%$ 8.282 millions
Stryker Corp7.25%$ 7.246 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com